The Incidence Of Human Papiloma Virus In Pregnant Women and the Vertical Transfer Rate at Vaginal Delivery The Incidence Of Human Papilloma Virus In Pregnant Women and the Vertical Transfer Rate at Vaginal Delivery

Main Article Content

Yüksel Kurban https://orcid.org/0000-0002-9409-652X
Yasemin Alan https://orcid.org/0000-0003-2680-814X
Ibrahim Uyar https://orcid.org/0000-0002-0198-1563
Izzet Sahin https://orcid.org/0000-0001-7644-5020
Izzet Sahin https://orcid.org/0000-0001-7644-5020

Keywords

Human Papilloma Virus, Pregnancy, Vaginal birth, newborn infections

Abstract

Objective: Among 200 different genotypes of HPV at least 40 are related with anogenital diseases. HPV not only increases the risk of cervical and anogenital malignancies but also causes sexually transmitted infections in women in fertile period. In the past decades, the rate HPV infections have incerasd all over the world. The majority of infections are asymptomatic or presents with few small condylomas that can be ignored easily.It is clear that HPV infection is sexually transmitted, however there is lack of sufficient data about the fetomaternal transmission. The aim of this study is to determine the prevalance of Human Papilloma Virus (HPV) in Turkish society and to find the rate of the vertical transmission of HPV in the HPV positive mothers that give birth by vaginal delivery.


Subject  and  Method: A total of 150 hospitalized women in full term with uterine contractions were enrolled in the study. Dacron swaps were taken from cervical canal of the hospitalized women and right after the delivery swaps were taken from the oro/nasopharynx of the babies.  The samples were analysed by Digene Hybrid Capture HPV DNA assay.


Results: Among 150 women, 8 had ceserian section for some reason and the remaining  142 women and their babies were evaluated for HPV positivity. Eleven pregnant women (7.7%) were HPV positive and none of the babies had HPV positivity.


Conclusion: When the complications of HPV infection are considered, this rate of HPV positivity can create a high medical problem in the near future.


Key Words: Human Papilloma Virus, Pregnancy, Vaginal birth, newborn infections

Downloads

Download data is not yet available.
Abstract 4 | PDF Downloads 0

References

References
1- Garland SM. Human papillomavirus update with a particular focus on cervical disease. Pathology. 2002;34:213–224. doi: 10.1080/00313020212469).
2- Michelle SL, Laimonis AL. Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol Mol Biol Rev. 2004 Jun; 68(2): 362–372. doi: 10.1128/MMBR.68.2.362-372.2004
3- Tseng CJ, Liang CC, Soong YK, Pao CC. Perinatal Transmission of Human Papillomavirus in Infants: Relationship Between Infection Rate and Mode of Delivery Obstet Gynecol 1998 Jan;91(1):92-6. doi: 10.1016/s0029-7844(97)00593-0
4- Medeiros LR, Ethur AB, Hilgert JB, Zanini RR, Berwanger O, Bozzetti MC, Mylius LC. Vertical transmission of the human papillomavirus: a systematic quantitative review. Cad Saude Publica. Cad Saude Publica 2005;21(4):1006-15. doi: 10.1590/s0102-311x2005000400003
5- Jach R, Galarowicz B,Huras H,Pawlik D,Basta T,Streb J,Wolski H,Ludwin A,Ludwin I. Vertical Transmission of HPV in Pregnancy. A Prospective Clinical Study of HPV-positive Pregnant Women. Ginekol Pol 2014 Sep;85(9):672-6. doi:10.17772/gp/1790
6-Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH, Turek LP. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis. 2004;31:57–62. doi: 10.1097/01.OLQ.0000105327.40288.DB.
7-Gultekin M,Zayifoglu M,Kucukyildiz KI,Dundar S,Boztas G,Turan HS,Hacikamiloglu E,Murtuza K,Keskinkilic B,Sencan I. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women. International Journal of Cancer 2018;142 (9): 1952-1958 doi: 10.1002/ijc.31212
8-Syrjanen S,Puranen M. Human Papillomavirus Infections in Children: The Potential Role of Maternal Transmission.Crit Rev Oral Biol Med 2000;11(2):259-74.doi: 10.1177/10454411000110020801
9- Takakuwa K, Mitsui T, Iwashita M, Kobayashi I, Suzuki A, Oda T, Torii Y, Matsumoto M, Yahata G, Tanaka K. Studies on the prevalence of human papillomavirus in pregnant women in Japan. J Perinat Med. 2006;34:77–79. doi:10.1515/jpm.2006.010
10-Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat NB, et al. Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study. Am J Obstet Gynecol. 1998;178:365–73. doi: 10.1016/s0002-9378(98)80027-6.
11-Koch A, Hanson SV, Hielsen HM, Palefsky J, Melbye M. HPV detection in children prior to sexual debut. Int J Cancer.1997;73(5):621-4. doi: 10.1002/(sici)1097-0215(19971127)73:5<621::aid-ijc1>3.0.co;2-z
12-Nobbenhuis MA, Helmerhorst TJ, Brule AJ van den, Rozendaal L, Bezemer PD, Voorhorst FJ, at al. High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer. 2002;87:75–80. doi: 10.1038/sj.bjc.6600367
13-Xavier Castellsagué, Teresa Drudis, Maria Paz Cañadas, Anna Goncé, Ramón Ros, José M Pérez at al. Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC infectios Diseases 2009; 9:74. Doi:10.1186/1471-2334-9-74
14-Syrjänen S. Current concepts on human papillomavirus infections in children. APMIS 2010 Jun;118(6-7):494-509. doi: 10.1111/j.1600-0463.2010.02620.x.
15-Maraes E, Loshimoto LM, Lego E, Zugaip M. Presence of HPV DNA in amniotik fluids in pregnantwomen with cervical lesions . Gynecol Oncology. 1994;54(2):152-8. doi: 10.1006/gyno.1994.1185.
16-Egger M, Smith GD, Schneider M. Systematic reviews of observational studies. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd Ed. London: BMJ Publishing Group; 2001. p. 211-27. doi: 10.1136/bmj.323.7304.101
17-Tenti P, Appatore R, Migliora P, Spinillo A, Belloni C. Perinatal transmission of human papillomavirus from gravidas with latend infection. Obstet Gynecol. 1999; 93 (4):475-9. doi: 10.1016/s0029-7844(98)00459-1.